Results 81 to 90 of about 6,178 (191)

Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?

Objective: To investigate the effect of switching from deferasirox dispersible tablet (DT) to deferasirox film-coated tablet (FCT) on serum ferritin (SF) levels in transfusion-dependent patients.
Ayşe Gonca Kaçar, Ayşe Özkan Karagenç, Cengiz Bayram, Esra Arslantaş, Tuba Nur Tahtakesen Güçer, Duygu Özkorucu Yıldırgan, Nihal Özdemir, Sibel Akpınar Tekgündüz, Ali Ayçiçek   +8 more
core   +1 more source

Evaluating Effectiveness of Deferasirox Versus Deferoxamine in Improving Clinical Outcomes among Patients with Transfusion-Dependent Thalassemia: A Randomized Controlled Trial

Link Medical Journal of Health and Community Research
Background: Transfusion-dependent β-thalassemia necessitates lifelong blood transfusions that progressively accumulate systemic iron, causing cardiomyopathy, hepatic cirrhosis, and endocrine failure without effective chelation. Deferasirox, a once-daily
Muhammad Mohsin Shoukat, Hafiza Khadija Tariq, Fareed Ullah, Muhammad Arslan Liaqat, Areeba Sajjad, Nauman Akhtar   +5 more
doaj   +1 more source

Pengaruh Deferasirox Terhadap Kadar T4 dan TSH Pada B-Thalassemia Mayor dengan Kadar Ferritin Tinggi

Sari Pediatri, 2016
Latar belakang. Iron overload pada pasien 􀁂-thalassemia mayor terjadi akibat transfusi berulang. Pengendapan besi terjadi terutama di jantung, hati dan kelenjar endokrin.
Dewi Ratih P, Rudy Susanto, Bambang Sudarmanto   +2 more
doaj   +1 more source

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report

Journal of Microbiology and Infectious Diseases, 2016
In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery.
Uğur Onal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, Oğuz Reşat Sipahi   +6 more
doaj   +1 more source

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes

, 2015
Paolo Ricchi,1 Maria Marsella1,2 1UOSD Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale “Antonio Cardarelli”, Naples, 2UOC Pediatria, Azienda Ospedaliera di Rilievo Nazionale G. Rummo, Benevento, Italy Abstract:
Ricchi P, Marsella M
core  

Deferasirox (Exjade) for the treatment of iron overload

, 2009
Deferasirox is a once-daily oral iron chelator with established dose-dependent efficacy in both adult and pediatric patients with transfusional iron overload.
A. Taher, M.D. Cappellini
core   +1 more source

Deferasirox származékok és komplexeik szintézise és vizsgálata

, 2020
A kutatómunka célja a deferasirox komplexek szintézise volt. Ligandumként alkalmazva a deferasiroxot feltételezéseink szerint kettős hatású komplexekhez juthatunk.
Ferenczik, Gergő Tamás
core  

Deferasirox desensitization [PDF]

The Journal of Allergy and Clinical Immunology: In Practice, 2016
Karen E, Bruner, Kevin M, White
openaire   +2 more sources

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload

, 2018
Dijiong Wu,1 Xiaowen Wen,2 Wenbin Liu,1 Huijin Hu,1 Baodong Ye,1 Yuhong Zhou1 1Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Internal ...
Wen X, Hu H, Ye B, Wu D, Zhou Y, Liu W
core  

Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use

, 2017
AimDeferasirox is a new oral iron chelating agent with several cases reporting renal adverse events in recent years. Our aim was to identify the incidence of deferasirox-related Fanconi syndrome (FS) and its risk factors.
莊國璨;蔡宜蓉;盧孟佑;曹永魁, Chuang, Gwo-Tsann;Tsai, I-Jung;Tsau, Yong-Kwei;Lu, Meng-Yao   +1 more
core   +1 more source